Literature DB >> 26309665

Impacts of parathyroidectomy on renal anemia and nutritional status of hemodialysis patients with secondary hyperparathyroidism.

Chen Chen1, Hua Wu1, Lin Zhong1, Xin Wang1, Zhuang-Jie Xing2, Bi-Hu Gao1.   

Abstract

The aim of this study was to investigate the impacts of parathyroidectomy (PTX) towards the renal anemia and nutritional status of hemodialysis patients with secondary hyperparathyroidism (SHPT). 32 patients, enrolled into the blood purification center of our hospital for the hemodialysis treatment, were collected and divided into the PTX group and the non-PTX group, with 16 patients in each group. The changes of relevant indicators such as immunoreactive parathyroid hormone (iPTH), anemia and nutrition were observed before, 1-, 3-, 6-month after the treatment. The contents of iPTH, Ca, P and Ca × P of the PTX group decreased rapidly 1 month after the surgery; while Hb and Hct increased significantly from the 1st postoperative month; the dosage of EPO was significantly reduced 3-month after the surgery; the content of Alb gradually increased from the 3(rd) postoperative month; the content of TG decreased significantly from the 6(th) postoperative month; while the contents of BMI and TSF increased significantly from the 6(th) postoperative month, which exhibited the statistically significant differences when compared with the preoperative and the non-PTX group (P < 0.05). PTX could quickly reduce the iPTH level and significantly improve the renal anemia and nutritional status; SHPT was the important factor that would affect the renal anemia and malnutrition; PTX could reduce the amount of EPO, and reduce the economic burden of patients.

Entities:  

Keywords:  Parathyroidectomy; nutrition; renal anemia; secondary hyperparathyroidism

Year:  2015        PMID: 26309665      PMCID: PMC4538062     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  24 in total

1.  Chronic renal failure, parathyroid hormone and fatty acids oxidation in skeletal muscle.

Authors:  M Smogorzewski; G Piskorska; P R Borum; S G Massry
Journal:  Kidney Int       Date:  1988-02       Impact factor: 10.612

2.  Resorptive hypercalcemia in post-essential thrombocythemia myelofibrosis: treatment with denosumab.

Authors:  Nadia Khoury; Julietta Chang; Alejandro A Gru; Michael P Whyte
Journal:  J Clin Endocrinol Metab       Date:  2012-06-22       Impact factor: 5.958

3.  Effects of a parathyroidectomy on the immune system and nutritional condition in chronic dialysis patients with secondary hyperparathyroidism.

Authors:  C Yasunaga; M Nakamoto; K Matsuo; G Nishihara; T Yoshida; T Goya
Journal:  Am J Surg       Date:  1999-10       Impact factor: 2.565

4.  Iron, inflammation, dialysis adequacy, nutritional status, and hyperparathyroidism modify erythropoietic response.

Authors:  Adam E Gaweda; Linda J Goldsmith; Michael E Brier; George R Aronoff
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-28       Impact factor: 8.237

5.  Is insulin resistance a risk factor for the progression of chronic kidney disease?

Authors:  Taner Bastürk; Abdulkadır Unsal
Journal:  Kidney Blood Press Res       Date:  2011-02-03       Impact factor: 2.687

Review 6.  Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.

Authors:  Connie M Rhee; Gregory A Brent; Csaba P Kovesdy; Offie P Soldin; Danh Nguyen; Matthew J Budoff; Steven M Brunelli; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

Review 7.  Patient independence in chronic kidney disease and anaemia: implications of the 2012 KDIGO guideline.

Authors:  Lesley Bennett
Journal:  J Ren Care       Date:  2013-06

8.  Evaluation of nutritional parameters of hemodialysis patients.

Authors:  K Kaynar; T Songul Tat; S Ulusoy; M Cansiz; G Ozkan; S Gul; O Bektas
Journal:  Hippokratia       Date:  2012-07       Impact factor: 0.471

9.  [Nutritional status and food intake of continuous peritoneal dialysis patients with and without secondary hyperparathyroidism].

Authors:  Sara Ribeiro Campos; Maria Helena Lima Gusmão; Alessandra Fortes Almeida; Luís José Cardoso Pereira; Lilian Ramos Sampaio; Jairza Maria Barreto Medeiros
Journal:  J Bras Nefrol       Date:  2012-06

10.  Relationship of associated secondary hyperparathyroidism to serum fibroblast growth factor-23 in end stage renal disease: a case-control study.

Authors:  Hamdy Sliem; Gamal Tawfik; Fadia Moustafa; Heba Zaki
Journal:  Indian J Endocrinol Metab       Date:  2011-04
View more
  4 in total

Review 1.  Secondary Hyperparthyroidism: Pathogenesis, Diagnosis, Preventive and Therapeutic Strategies.

Authors:  Mariano Rodríguez Portillo; María E Rodríguez-Ortiz
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

2.  Effect of parathyroidectomy on bone tissue biomarkers and body composition in patients with chronic kidney disease and secondary hyperparathyroidism.

Authors:  Flavia Ramos de Siqueira; Karin Carneiro de Oliveira; Wagner Vasques Dominguez; César Augusto Madid Truyts; Rosa Maria Affonso Moysés; Luciene Machado Dos Reis; Vanda Jorgetti
Journal:  Eur J Clin Nutr       Date:  2021-01-18       Impact factor: 4.016

3.  Neutrophil gelatinase-associated lipocalin reflects the severity of anemia without iron deficiency and secondary hyperparathyroidism in hemodialysis patients.

Authors:  Irem Pembegul Yigit; Ramazan Ulu; Nevzat Gozel; Hulya Taskapan; Necip Ilhan; Ayhan Dogukan
Journal:  North Clin Istanb       Date:  2017-05-10

4.  Impact of parathyroidectomy among nondiabetic hemodialysis patients with severe hyperparathyroidism.

Authors:  Qing-Xiu Huang; Jie Pang; Chuan-Ke Shi; Xiao-Wen Huang; Xiao-Fang Chen; Yan-Feng Luo; Hai-Wen An; Jian-Lin Jian; Linna Liu; Yan-Lin Li
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.